Stemtech annual revenue
2020
2021
2022
2023
2024
2025
Stemtech reported $2.9M in revenue for fiscal 2025, a decrease of 43.08% from the previous fiscal year.
View full Stemtech company overview| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $2.9M | −$2.2M | −43.08% |
| 2024 | 2024-12-31 | $5.1M | $132,159 | +2.69% |
| 2023 | 2023-12-31 | $4.9M | $362,132 | +7.94% |
| 2022 | 2022-12-31 | $4.6M | $238,154 | +5.51% |
| 2021 | 2021-12-31 | $4.3M | −$63,262 | −1.44% |
| 2020 · Dec 31 | 2020-12-31 | $4.4M | — | — |
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $629,312 | −$68,613 | −9.83% |
| Q1 2026 | 2026-03-31 | $462,957 | −$405,089 | −46.67% |
| Q4 2025 | 2025-12-31 | $458,109 | −$855,581 | −65.13% |
| Q3 2025 | 2025-09-30 | $852,300 | −$179,330 | −17.38% |
| Q2 2025 | 2025-06-30 | $697,925 | −$627,875 | −47.36% |
| Q1 2025 | 2025-03-31 | $868,046 | −$514,524 | −37.22% |
| Q4 2024 | 2024-12-31 | $1.3M | −$48,052 | −3.53% |
| Q3 2024 | 2024-09-30 | $1.0M | −$266,692 | −20.54% |
| Q2 2024 | 2024-06-30 | $1.3M | $197,674 | +17.52% |
| Q1 2024 | 2024-03-31 | $1.4M | $249,229 | +21.99% |
| Q4 2023 | 2023-12-31 | $1.4M | $282,105 | +26.13% |
| Q3 2023 | 2023-09-30 | $1.3M | $251,292 | +24.00% |
| Q2 2023 | 2023-06-30 | $1.1M | −$148,298 | −11.62% |
| Q1 2023 | 2023-03-31 | $1.1M | −$22,967 | −1.99% |
| Q4 2022 | 2022-12-31 | $1.1M | — | — |
| Q3 2022 | 2022-09-30 | $1.0M | $139,176 | +15.33% |
| Q2 2022 | 2022-06-30 | $1.3M | $251,312 | +24.52% |
| Q1 2022 | 2022-03-31 | $1.2M | $80,547 | +7.49% |
| Q3 2021 | 2021-09-30 | $907,854 | −$151,599 | −14.31% |
| Q2 2021 · Jun 30 | 2021-06-30 | $1.0M | — | — |
| Q1 2021 · Mar 31 | 2021-03-31 | $1.1M | — | — |
| Q3 2020 · Sep 30 | 2020-09-30 | $1.1M | — | — |
Over the last five reported fiscal years, revenue declined from $4.4M to $2.9M, a compound annual decline of 8.09%. Stemtech's latest reported quarter, Q2 2026, generated $629,312 in revenue, a decrease of 9.83% year over year.
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Stemtech source filings ↗